INVO Bioscience Inc. (INVO)
NASDAQ: INVO
· Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM
INVO Bioscience Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.03B | 8.17B | 6.53B | 6.23M | 5.77M | 4.25M | 3.02M | 1.92M | 1.18M | 1.01M | 822.2K | 3.59M | 3.58M | 3.64M | 4.16M | 1.31M | 1.43M | 1.46M |
Cost of Revenue | 5.79B | 4.7B | 3.66B | 3.81M | 3.41M | 2.8M | 1.8M | 988.13K | 516.28K | 453.47K | 445.88K | 413.98K | 325.28K | 147.27K | 145.05K | 107.96K | 114.94K | 121.51K |
Gross Profit | 4.24B | 3.47B | 2.87B | 2.18M | 2.13M | 1.45M | 1.22M | 928.83K | 661.11K | 554.15K | 376.32K | 3.18M | 3.25M | 3.49M | 4.02M | 1.2M | 1.31M | 1.34M |
Operating Income | -28.22B | -25.23B | -8.13B | -5.66M | -5.24M | -5.41M | -6.77M | -7.98M | -9.62M | -10.23M | -10.63M | -7.4M | -7.15M | -6.36M | -5.22M | -7.51M | -6.5M | -5.68M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34.00 | 82.00 | 307.00 | 369.00 | 335.00 | 2.71K | 4.5K | 8.63K | 8.63K | 6.2K |
Pretax Income | -29.73B | -26.52B | -9.12B | -7.41M | -7.06M | -7.05M | -8.01M | -8.8M | -10.1M | -10.67M | -10.89M | -8.02M | -7.95M | -6.97M | -6.65M | -10.56M | -9.85M | -9.36M |
Net Income | -32.03B | -26.75B | -9.35B | -7.47M | -7.08M | -7.08M | -8.5M | -9.27M | -10.59M | -11.15M | -10.99M | -8.36M | -8.03M | -7.05M | -6.65M | -10.32M | -9.85M | -9.36M |
Selling & General & Admin | 13.82B | 11.63B | 9.08B | 7.46M | 7.2M | 6.6M | 7.66M | 8.65M | 9.87M | 10.27M | 10.46M | 10.05M | 9.99M | 9.59M | 9.02M | 8.33M | 7.38M | 6.59M |
Research & Development | 755.32M | 755.32M | 489.66M | 10.79K | 13.46K | 97.31K | 165.94K | 233.87K | 406.47K | 513.38K | 544.04K | 533.96K | 414.09K | 254.34K | 216.43K | 373.61K | 430.77K | 434.64K |
Other Expenses | 17.88B | 16.31B | 1.43B | 641.22K | 431.23K | 220.6K | 220.6K | 40.21K | 19.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 32.46B | 28.7B | 11B | 7.84M | 7.38M | 6.86M | 7.99M | 8.91M | 10.28M | 10.79M | 11M | 10.58M | 10.4M | 9.85M | 9.23M | 8.71M | 7.81M | 7.02M |
Interest Expense | -1.59B | -1.37B | -1.06B | 1.01M | 1.09M | 890.62K | 925.91K | 799.99K | 449.67K | 274.58K | 59.45K | 189.78K | 281.41K | 372.43K | 1.27M | 3.1M | 3.52M | 3.68M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.46B | -2.92B | -2.92B |
Cost & Expenses | 38.25B | 33.4B | 14.66B | 11.89M | 11.01M | 9.66M | 9.79M | 9.89M | 10.79M | 11.24M | 11.45M | 11M | 10.73M | 10M | 9.38M | 8.82M | 7.93M | 7.14M |
Income Tax Expense | 2.05B | -22.91M | -22.91M | 54.13K | 26.76K | 29.62K | 488.83K | 467.87K | 490.19K | 488.13K | 100.45K | 103.14K | 78.94K | 78.14K | 4.76K | 36.00 | 36.00 | 36.00 |
Shares Outstanding (Basic) | 397.44K | 138.91K | 3.1M | 3.89M | 3.61M | 3.8M | 1.57M | 1.78M | 732.25K | 622.5K | 608.41K | 607.78K | 605.76K | 602.53K | 523.2K | 523.2K | 522.21K | 494.4K |
Shares Outstanding (Diluted) | 397.44K | 138.91K | 3.1M | 3.89M | 3.61M | 3.8M | 1.57M | 1.78M | 732.25K | 622.5K | 608.41K | 607.78K | 605.76K | 602.53K | 523.2K | 523.2K | 522.21K | 494.4K |
EPS (Basic) | -128.31K | -128.3K | -3.02K | -2.73 | -3.01 | -5.45 | -9.87 | -13.15 | -16.68 | -18.24 | -18.13 | -13.85 | -13.91 | -12.77 | -13 | -28.39 | -31.25 | -33.13 |
EPS (Diluted) | -128.31K | -128.3K | -3.02K | -2.73 | -3.01 | -5.45 | -9.87 | -13.15 | -16.68 | -18.24 | -18.13 | -13.85 | -13.91 | -12.77 | -13 | -28.39 | -31.25 | -33.13 |
EBITDA | -29.64B | -26.38B | -9.51B | -5.58M | -5.35M | -5.75M | -6.87M | -7.85M | -9.51M | -10.18M | -10.58M | -7.44M | -7.27M | -6.24M | -5.09M | -7.38M | -6.28M | -5.64M |
EBIT | -17.1B | -17.11B | n/a | -6.41M | -5.97M | -6.16M | -7.08M | -8M | -9.65M | -10.39M | -10.83M | -7.62M | -7.46M | -6.38M | -5.17M | -7.46M | -6.34M | -5.67M |
Depreciation & Amortization | 1.32B | 1.15B | 919.6M | 829.39K | 619.4K | 408.77K | 258.75K | 194.71K | 251.31K | 310.82K | 306.32K | 308.12K | 262.6K | 214.94K | 151.05K | 80.31K | 57.54K | 34.53K |